Molecular Basis for Protein-specific Transfer of N-Acetylgalactosamine to N-Linked Glycans by the Glycosyltransferases β1,4-N-Acetylgalactosaminyl Transferase 3 (β4GalNAc-T3) and β4GalNAc-T4
Molecular Basis for Protein-specific Transfer of N-Acetylgalactosamine to N-Linked Glycans by the Glycosyltransferases β1,4-N-Acetylgalactosaminyl Transferase 3 (β4GalNAc-T3) and β4GalNAc-T4
复制标题
DOI:
10.1074/jbc.m112.371567
复制
发表时间:
2012-08-17
影响因子:
4.8
通讯作者:
Baenziger, Jacques U.
中科院分区:
文献类型:
--
作者:
Fiete, Dorothy;Beranek, Mary;Baenziger, Jacques U.
Two closely related beta 1,4-N-acetylgalactosaminyltransferases, beta 4GalNAc-T3 and beta 4GalNAc-T4, are thought to account for the protein-specific addition of beta 1,4-linked GalNAc to Asn-linked oligosaccharides on a number of glycoproteins including the glycoprotein hormone luteinizing hormone and carbonic anhydrase-6 (CA6). We have utilized soluble, secreted forms of beta 4GalNAc-T3 and beta 4GalNAc-T4 to define the basis for protein-specific GalNAc transfer in vitro to chimeric substrates consisting of Gaussia luciferase followed by a glycoprotein substrate. Transfer of GalNAc by beta 4GalNAc-T3 and beta 4GalNAc-T4 to terminal GlcNAc is divalent cation-dependent. Transfer of GalNAc to glycoprotein acceptors that contain a peptide recognition determinant is maximal between 0.5 and 1.0 mM MnCl2; however, transfer is increasingly inhibited by concentrations of MnCl2 above 1 mM and by anion concentrations above 15 mM. In contrast, transfer of GalNAc to the simple sugar acceptor N-acetylglucosamine-beta-p-nitrophenol (GlcNAc beta-pNP) is not inhibited by concentrations of MnCl2 or anions that would inhibit transfer to glycoprotein acceptors by >90%. This finding indicates that interaction with the peptide recognition determinant in the substrate is sensitive to the anion concentration. beta 4GalNAc-T3 and beta 4GalNAc-T4 have similar but distinct specificities, resulting in a 42-fold difference in the IC50 for transfer of GalNAc to chimeric glycoprotein substrates by agalacto human chorionic gonadotropin, comprising 29 nM for beta 4GalNAc-T3 and 1.2 mu M for beta 4GalNAc-T4. Our in vitro analysis indicates that enzymatic recognition of the peptide determinant and the oligosaccharide acceptor are independent events.